Maven Clinical Cloud Discussions

JNPMEDI Inc. is a South Korean technology company founded in 2020, that develops and services ‘MavenClinicalCloud’, a SaaS (software as a service) for clinical trial operation and data management. We are leading the digital transformation of the clinical trials industry to achieve patient-centric, cost-efficient, and timely studies, allowing the delivery of life-saving medication and devices to patients in need. The 3 key differentiators of our solution are: •Modular and Sponsor value-centered pricing structure data transaction-based pricing along with a modular design enables a true pay-as-you-go pricing structure for a 30-40% reduction in CDMS pricing •In-house Building for a timely, tailored, and flexible solution onboarding by Maven Consulting Team reduces build time by 20-30% while allowing full customization and connection to third-party tools and solutions •Inspection-ready, secure, and compliant global standards tamper-proof data protection with a patented blockchain-based QMS (quality management system) that is ISO-certified and 21 CFR Part 11-compliant When users leave Maven Clinical Cloud reviews, G2 also collects common questions about the day-to-day use of Maven Clinical Cloud. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.